(1) There is hereby created the Mississippi Medical Cannabis Research Program at the National Center for Cannabis Research and Education at the University of Mississippi.
(2) Subject to funding, the program:(a) Shall seek state, federal and private funds to award grants for medical cannabis research;(b) Shall facilitate and support funding for research related to the health effects, including the potential risks or side effects, of the use of cannabis products;(c) Shall facilitate and support funding for research related to the efficacy and potential health effects of various cannabis delivery methods, including vaporizing, ingesting, topical application, and combustion;(d) Shall support researchers in applying for and securing federal and private research grant funding for expanding medical cannabis research;(e) Shall review current and future cannabis research literature, clinical studies, and clinical trials;(f) Shall educate medical providers, lawmakers, and the public about medical cannabis research advances;(g) Shall, if requested, consult with researchers and eligible institutions seeking to conduct medical cannabis research regarding legal implications of the research under state and federal law;(h) Shall monitor, to the extent that is appropriate and when sufficient data is available, patient outcomes in any state with a medicinal cannabis program;(i) May coordinate, share knowledge, and share best practices with a state:(i) That has a medical cannabis program; and(ii) Is conducting cannabis research;(j) May award or facilitate funding for grants to an eligible institution for medical cannabis research, including research regarding the growing of a medical-grade cannabis plant that is used for a cannabis product;(k) May support a licensed cannabis cultivation facility to provide medical-grade cannabis products for research;(l) Shall make, for research conducted by the program, the research outcomes publicly available;(m) Shall maintain a catalog of all published scientific reports based on projects funded or managed by the program;(n) Shall ensure that an individual who agrees to use a cannabis product as part of a research project conducted by the program or a grantee:(i) Is a registered, qualifying patient cardholder; or(ii) If included in the research project as a resident of another state, has the equivalent of such certification under the laws of another state, district, territory, commonwealth or insular possession of the United States;(o) Shall provide information to the Department of Health describing:(i) All research projects that are funded by a grant awarded by the program, including which institution received the grant;(ii) All research projects conducted by the program; and(iii) The adequacy of funding for the program’s duties.
(a) Shall seek state, federal and private funds to award grants for medical cannabis research;
(b) Shall facilitate and support funding for research related to the health effects, including the potential risks or side effects, of the use of cannabis products;
(c) Shall facilitate and support funding for research related to the efficacy and potential health effects of various cannabis delivery methods, including vaporizing, ingesting, topical application, and combustion;
(d) Shall support researchers in applying for and securing federal and private research grant funding for expanding medical cannabis research;
(e) Shall review current and future cannabis research literature, clinical studies, and clinical trials;
(f) Shall educate medical providers, lawmakers, and the public about medical cannabis research advances;
(g) Shall, if requested, consult with researchers and eligible institutions seeking to conduct medical cannabis research regarding legal implications of the research under state and federal law;
(h) Shall monitor, to the extent that is appropriate and when sufficient data is available, patient outcomes in any state with a medicinal cannabis program;
(i) May coordinate, share knowledge, and share best practices with a state:(i) That has a medical cannabis program; and(ii) Is conducting cannabis research;
(i) That has a medical cannabis program; and
(ii) Is conducting cannabis research;
(j) May award or facilitate funding for grants to an eligible institution for medical cannabis research, including research regarding the growing of a medical-grade cannabis plant that is used for a cannabis product;
(k) May support a licensed cannabis cultivation facility to provide medical-grade cannabis products for research;
(l) Shall make, for research conducted by the program, the research outcomes publicly available;
(m) Shall maintain a catalog of all published scientific reports based on projects funded or managed by the program;
(n) Shall ensure that an individual who agrees to use a cannabis product as part of a research project conducted by the program or a grantee:(i) Is a registered, qualifying patient cardholder; or(ii) If included in the research project as a resident of another state, has the equivalent of such certification under the laws of another state, district, territory, commonwealth or insular possession of the United States;
(i) Is a registered, qualifying patient cardholder; or
(ii) If included in the research project as a resident of another state, has the equivalent of such certification under the laws of another state, district, territory, commonwealth or insular possession of the United States;
(o) Shall provide information to the Department of Health describing:(i) All research projects that are funded by a grant awarded by the program, including which institution received the grant;(ii) All research projects conducted by the program; and(iii) The adequacy of funding for the program’s duties.
(i) All research projects that are funded by a grant awarded by the program, including which institution received the grant;
(ii) All research projects conducted by the program; and
(iii) The adequacy of funding for the program’s duties.
(3) For research funded, conducted, or facilitated by the program, the program shall ensure the research:(a) Includes appropriate research development, testing, and evaluation; and(b) If the research involves human subjects, is reviewed, approved, and overseen by an institutional review board.
(a) Includes appropriate research development, testing, and evaluation; and
(b) If the research involves human subjects, is reviewed, approved, and overseen by an institutional review board.
(4) The University of Mississippi shall provide staff for the program.